Taking Aim at Dry Eye - Sponsored by TheraTears - September 2017

Taking Aim at Dry Eye

Sponsored by TheraTears.

This latest and thoroughly vetted appraisal of dry eye and its profoundly invasive nature, as well as expanding knowledge about DED’s features, its response to various therapies and management plans, and the trajectory it likely will take is helping eye care professionals secure the right tools to thwart the forward momentum of dry eye. Clinicians are better poised than ever to offer greater comfort and peace of mind to patients suffering from the chronic burden of this disease.
- Terrence P. O’Brien, MD